Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine for irritable bowel syndrome
IRCT20181118041691N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of venlafaxine in irritable bowel syndrome (IBS) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Quality of life score, Stress, anxiety and depression score and 1 more. Started Jan 2017; status: completed.
02
Drugs
venlafaxine
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on IRCT20181118041691N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181118041691N1.